No Data
Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Shares of ASLAN Pharmaceuticals Limited (NASDAQ:ASLN) fell sharply during Wednesday's session after the company announced that its Singapore-incorporated, sole operating subsidiary has filed for
BofA Securities Maintains Luminar Technologies(LAZR.US) With Sell Rating, Maintains Target Price $1.2
BofA Securities analyst John Babcock maintains $Luminar Technologies(LAZR.US)$ with a sell rating, and maintains the target price at $1.2.According to TipRanks data, the analyst has a success rate
Luminar Technologies Sell Rating Justified Amidst Shifting LIDAR Industry Dynamics
Investors in Luminar Technologies (NASDAQ:LAZR) From Three Years Ago Are Still Down 89%, Even After 26% Gain This Past Week
Luminar Technologies Price Target Cut to $1.00/Share From $1.50 by Goldman Sachs
Luminar Technologies Price Target Cut to $1.00/Share From $1.50 by Goldman
Luminar Technologies Is Maintained at Sell by Goldman Sachs
Luminar Technologies Is Maintained at Sell by Goldman